Research Articles | Page 15 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity Aug 2020 International Journal of Hematology Myelodysplastic Syndromes (MDS)
High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag Jul 2020 Leukemia Aplastic Anemia
Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter? Mar 2020 Expert Review of Hematology Myelodysplastic Syndromes (MDS)
How I Diagnose Low-Grade Myelodysplastic Syndromes May 2020 American Journal of clinical Pathology Myelodysplastic Syndromes (MDS)
How I Treat Paroxysmal nocturnal hemoglobinuria Jan 2021 Blood Paroxysmal Nocturnal Hemoglobinuria (PNH)
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities Mar 2020 Clinical Lymphoma , Myeloma & Leukemia Myelodysplastic Syndromes (MDS)
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Apr 2024 Haematologica Aplastic Anemia
Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome Dec 2019 Hematology. American Society of Hematology. Education Program Aplastic Anemia
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Jan 2020 Journal of clinical oncology: official journal of the American Society Clinical Oncology Myelodysplastic Syndromes (MDS)
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Oct 2020 Journal of clinical oncology: official journal of the American Society Clinical Oncology Myelodysplastic Syndromes (MDS)